Atropine, a muscarinic cholinergic receptor antagonist increases serotonin, but not dopamine levels in discrete brain regions of mice

Neuroscience Letters

Volumn 423, Issue 2, 2007, Pages 100-103

  Kumari, Amrita ^a   Sreetama, Sen ^a   Mohanakumar, Kochupurackal P ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Acetylcholine; Atropine; Balb c mice; Dopamine; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG EFFECT; ELECTROCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM;

ANIMALS; ATROPINE; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED BALB C; MUSCARINIC ANTAGONISTS; SEROTONIN;

EID: 34547887234     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.06.027     Document Type: Article

References (23)

1. Blomeley C., and Bracci E. Excitatory effects of serotonin on rat striatal cholinergic interneurones. J. Physiol. 569 (2005) 715-721
2. Cassel J.C., and Jeltsch H. Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience 69 (1995) 1-41
3. 1A) receptor-mediated responses by the cholinergic system. Int. J. Neuropsychopharmacol. 7 (2004) 391-399
4. Haddjeri N., Lucas G., and Blier P. Role of cholinergic and GABAergic systems in the feedback inhibition of dorsal raphe 5-HT neurons. Neuroreport 11 (2000) 397-401
5. Hery F., Bourgoin S., Hamon M., Ternaux J.P., and Glowinski J. Control of the release of newly synthetized 3H-5-hydroxytryptamine by nicotinic and muscarinic receptors in rat hypothalamic slices. Naunyn Schmiedebergs Arch. Pharmacol. 296 (1977) 91-97
6. INSA. Guidelines for Care and Use of Animals in Scientific Research (2000), Indian National Science Academy Publication, New Delhi pp. 1-26
7. Kenny P.J., File S.E., and Neal M.J. Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J. Neurochem. 75 (2000) 2409-2414
8. Mehta H., Haobam R., Usha R., and Mohanakumar K.P. Evidence for the involvement of central serotoninergic mechanisms in cholinergic tremor induced by tacrine. Behav. Brain Res. 163 (2005) 227-236
9. Mehta H., Saravanan K.S., and Mohanakumar K.P. Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice. Behav. Brain Res. 145 (2003) 31-36
10. Mehta H., Thomas B., and Mohanakumar K.P. Effects of p-chlorophenylalanine on striatal acetylcholinesterase activity and on biogenic amine levels in raphe, tuberculum olfactorium and caudate-putamen during physostigmine-induced tremor in rats. Neurosci. Lett. 299 (2001) 105-108
11. Mohanakumar K.P., Mitra N., and Ganguly D.K. Tremorogenesis by physostigmine is unrelated to acetylcholinesterase inhibition: evidence for serotoninergic involvement. Neurosci. Lett. 120 (1990) 91-93
12. Muralikrishnan D., and Mohanakumar K.P. Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced neurotoxicity in mice. FASEB J. 12 (1998) 905-912
13. Nair S.G., and Gudelsky G.A. 3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat. Psychopharmacology 184 (2006) 182-189
14. Nair S.G., and Gudelsky G.A. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex. Brain Res. Bull. 69 (2006) 382-387
15. Ogren S.O., Carlsson S., and Bartfai T. Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse. Psychopharmacology 86 (1985) 258-264
16. Palkovits M., and Brownstein M.J. Microdissection of brain areas by punch techniques. In: Cuello A.C. (Ed). Brain Microdissection Techniques (1983), John Willey & Sons, New York 1-36
17. Rausch J.L., Shah N.S., Burch E.A., and Donald A.G. Platelet serotonin uptake in depressed patients: circadian effect. Biol. Psychiat. 17 (1982) 121-123
18. Sarkar S., Thomas B., Muralikrishnan D., and Mohanakumar K.P. Effects of serotoninergic drugs on tremor induced by physostigmine. Behav. Brain Res. 109 (2000) 167-193
19. Seth P., Cheeta S., Tucci S., and File S.E. Nicotinic-serotonergic interactions in brain and behaviour. Pharmacol. Biochem. Behav. 71 (2002) 795-805
20. Sethy V.H., and Van Woert M.H. Antimuscarinic drugs-effect on brain acetylcholine and tremors in rats. Biochem. Pharmacol. 22 (1973) 2685-2691
21. Singer S., Rossi S., Verzosa S., Hashim A., Lonow R., Cooper T., Sershen H., and Lajtha A. Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function. Neurochem. Res. 29 (2004) 1779-1792
22. Tucci S.A., Genn R.F., and File S.E. Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors. Neuropharmacology 44 (2003) 367-373
23. Vizi E.S., Harsing Jr. L.G., and Zsilla G. Evidence of the modulatory role of serotonin in acetylcholine release from striatal interneurons. Brain Res. 212 (1981) 89-99